HomeNGENF • OTCMKTS
add
NervGen Pharma Corp
Previous close
$4.37
Day range
$4.16 - $4.75
Year range
$1.50 - $5.10
Market cap
487.95M CAD
Avg Volume
138.30K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.17M | -14.61% |
Net income | -4.16M | 21.52% |
Net profit margin | — | — |
Earnings per share | -0.06 | 14.29% |
EBITDA | -6.16M | 14.63% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.36M | -45.91% |
Total assets | 13.08M | -41.77% |
Total liabilities | 16.02M | 20.62% |
Total equity | -2.94M | — |
Shares outstanding | 78.34M | — |
Price to book | -109.30 | — |
Return on assets | -102.84% | — |
Return on capital | 818.57% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -4.16M | 21.52% |
Cash from operations | -5.32M | 7.57% |
Cash from investing | 25.23K | 0.00% |
Cash from financing | 995.20K | 268.95% |
Net change in cash | -4.31M | 22.36% |
Free cash flow | -5.01M | 1.22% |
About
Founded
2017
Headquarters
Website
Employees
10
